Hovingh GK - Search Results

1

PCSK9 as predictor for recurrent cardiovascular disease in familial hypercholesterolemia.

Reeskamp LF, Tromp TR, Hovingh GK. Reeskamp LF, et al. Among authors: hovingh gk. Eur J Prev Cardiol. 2021 Apr 23;28(3):270-271. doi: 10.1177/2047487319886140. Eur J Prev Cardiol. 2021. PMID: 31752531 Free article. No abstract available.

2

PCSK9 inhibitors: Novel therapeutic agents for the treatment of hypercholesterolemia.

Verbeek R, Stoekenbroek RM, Hovingh GK. Verbeek R, et al. Among authors: hovingh gk. Eur J Pharmacol. 2015 Sep 15;763(Pt A):38-47. doi: 10.1016/j.ejphar.2015.03.099. Epub 2015 May 16. Eur J Pharmacol. 2015. PMID: 25989132 Review.

3

Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.

Besseling J, Hovingh GK, Huijgen R, Kastelein JJP, Hutten BA. Besseling J, et al. Among authors: hovingh gk. J Am Coll Cardiol. 2016 Jul 19;68(3):252-260. doi: 10.1016/j.jacc.2016.04.054. J Am Coll Cardiol. 2016. PMID: 27417002 Free article.

4

Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.

Pećin I, Hartgers ML, Hovingh GK, Dent R, Reiner Ž. Pećin I, et al. Among authors: hovingh gk. Eur J Prev Cardiol. 2017 Sep;24(13):1383-1401. doi: 10.1177/2047487317717346. Epub 2017 Jun 23. Eur J Prev Cardiol. 2017. PMID: 28644091 Free PMC article. Review.

5

A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.

Reeskamp LF, Hartgers ML, Peter J, Dallinga-Thie GM, Zuurbier L, Defesche JC, Grefhorst A, Hovingh GK. Reeskamp LF, et al. Among authors: hovingh gk. Circ Genom Precis Med. 2018 Dec;11(12):e002385. doi: 10.1161/CIRCGEN.118.002385. Circ Genom Precis Med. 2018. PMID: 30562117

6

Hypercholesterolemia Among Premature Infarcts: Time to Start the Clock of Familial Hypercholesterolemia Assessment.

Hovingh GK, Reeskamp LF, Ray KK. Hovingh GK, et al. J Am Coll Cardiol. 2019 May 21;73(19):2451-2453. doi: 10.1016/j.jacc.2019.02.058. J Am Coll Cardiol. 2019. PMID: 31097166 Free article. No abstract available.

7

Taking One Step Back in Familial Hypercholesterolemia: STAP1 Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans.

Loaiza N, Hartgers ML, Reeskamp LF, Balder JW, Rimbert A, Bazioti V, Wolters JC, Winkelmeijer M, Jansen HPG, Dallinga-Thie GM, Volta A, Huijkman N, Smit M, Kloosterhuis N, Koster M, Svendsen AF, van de Sluis B, Hovingh GK, Grefhorst A, Kuivenhoven JA. Loaiza N, et al. Among authors: hovingh gk. Arterioscler Thromb Vasc Biol. 2020 Apr;40(4):973-985. doi: 10.1161/ATVBAHA.119.313470. Epub 2020 Jan 30. Arterioscler Thromb Vasc Biol. 2020. PMID: 31996024 Free PMC article.

8

ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia.

Reeskamp LF, Volta A, Zuurbier L, Defesche JC, Hovingh GK, Grefhorst A. Reeskamp LF, et al. Among authors: hovingh gk. J Clin Lipidol. 2020 Mar-Apr;14(2):207-217.e7. doi: 10.1016/j.jacl.2020.01.007. Epub 2020 Jan 29. J Clin Lipidol. 2020. PMID: 32088153

9

Gene-based therapy in lipid management: the winding road from promise to practice.

Tromp TR, Stroes ESG, Hovingh GK. Tromp TR, et al. Among authors: hovingh gk. Expert Opin Investig Drugs. 2020 May;29(5):483-493. doi: 10.1080/13543784.2020.1757070. Epub 2020 Apr 29. Expert Opin Investig Drugs. 2020. PMID: 32349563 Free article. Review.

10

Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans.

Kastelein JJP, Reeskamp LF, Hovingh GK. Kastelein JJP, et al. Among authors: hovingh gk. J Am Coll Cardiol. 2020 May 26;75(20):2567-2569. doi: 10.1016/j.jacc.2020.03.058. J Am Coll Cardiol. 2020. PMID: 32439006 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters